Dyne Therapeutics

Targeted genetic therapies for people with genetically driven neuromuscular diseases

Waltham, United StatesFounded 2017dyne-tx.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

Recent signals

What changed at Dyne Therapeutics in the last 6 months, newest first. Each line links to its public source.

Get signals like these for the companies you sell to →

About Dyne Therapeutics

Dyne Therapeutics develops targeted nucleic acid therapies for genetically driven neuromuscular diseases using its FORCE platform, which links a transferrin receptor 1-binding Fab to a therapeutic payload. Its pipeline includes clinical programs for Duchenne muscular dystrophy and myotonic dystrophy type 1, and preclinical programs for other conditions.

The company is based in Waltham, Massachusetts, and was founded in 2017. Its open roles span research, clinical development, manufacturing, medical affairs, and commercialization.

Product: A platform and pipeline of targeted therapies for genetically driven neuromuscular diseases.

Jobs at Dyne Therapeutics

No open positions in Europe right now.

Open roles at Dyne Therapeutics in the Americas (3)

United States 3. From Dyne Therapeutics's careers page or applicant tracking system; each role links to the employer.

More biotech & pharma companies

  • Dyno Therapeutics

    AI-enabled genetic technology development for biotechnology and medicine developers
    United StatesBiotech & pharma
    New on Evolc
  • Earli

    Develops genetic switches that activate in cancer cells for cancer detection and therapeutic applications
    United StatesBiotech & pharma
    New on Evolc
  • Editas Medicine

    Genome-editing medicines for people living with serious diseases
    United StatesBiotech & pharma
    New on Evolc
  • Emeraldcloudlab

    Remotely controlled life science lab letting pharma, biotech and academic teams run wet-lab experiments through software
    United StatesBiotech & pharma
    New on Evolc
  • Erasca

    Clinical-stage precision oncology company developing therapies that target the RAS/MAPK cancer signaling pathway
    United StatesBiotech & pharma
    New on Evolc
  • EVERY™

    Animal-free egg white protein ingredients (OvoPro) made by precision fermentation for food manufacturers and foodservice
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Privacy & consent

  • CookiebotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • GreenhouseMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.